Clinical Trial Update: A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial (Delphinus) assessed flexible-dose brexpiprazole as adjunctive treatment for adults with major depressive disorder; the study has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Depressive Disorder, Depression | Phase 3 | Status: COMPLETED | Results posted: 2018-06-08